A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor

Published:2006-10-02 Issue:8 Volume:177 Page:5032-5040
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Nagy Zsuzsanna S.,Rui Hallgeir,Stepkowski Stanislaw M.,Karras James,Kirken Robert A.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference67 articles.

1. Regulation of Lymphoid Cell Apoptosis by Jaks and Stats;

2. Stat3 Activation Is Required for Cellular Transformation by v- src

3. Activation and association of Stat3 with Src in v-Src-transformed cell lines

4. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells;Biochemistry and Biophysics Reports;2020-12

2. Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers;Cancers;2020-01-18

3. A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells;Cancers;2019-12-17

4. Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways;Scientific Reports;2019-04-12

5. Signal Transducer and Activator of Transcription of 5A and S3 (STAT5 and STATS3);Angiogenesis in Health, Disease and Malignancy;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3